(Q36895749)

16 August 2017

1 reference

title

Chronic hepatitis C virus infection: genotyping and its clinical role (English)

1 reference

16 August 2017

1 reference

1 reference

1 reference

1 reference

D Scott Bowden

1

1 reference

16 August 2017

Mark D Berzsenyi

series ordinal

2

1 reference

16 August 2017

publication date

1 June 2006

1 reference

16 August 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

16 August 2017

volume

1

1 reference

16 August 2017

issue

1

1 reference

16 August 2017

page(s)

103-112

1 reference

Global epidemiology of hepatitis C virus infection

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Recurrence of hepatitis C infection: Where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Characterization and evolution of NS5A quasispecies of hepatitis C virus genotype 1b in patients with different stages of liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Hepatitis C virus genetic variability: pathogenic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Genetic diversity and evolution of hepatitis C virus--15 years on

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Reconstructing the origins of human hepatitis viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

A proposed system for the nomenclature of hepatitis C viral genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Clinical significance of hepatitis C virus genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Hepatitis C virus genotypes in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

A genetic analysis of hepatitis C virus transmission between injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Transmission of HCV in the Vietnamese community

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Comparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Population genotyping of hepatitis C virus by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis of short DNA fragments.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Genotyping of hepatitis C virus by Taqman real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Genotyping of hepatitis C virus types 1, 2, 3, and 4 by a one-step LightCycler method using three different pairs of hybridization probes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Southeast Asian patients with chronic hepatitis C: the impact of novel genotypes and race on treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

HCV genotyping by three methods: analysis of discordant results based on sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Use and interpretation of hepatitis C virus diagnostic assays

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Protection against chronic hepatitis C virus infection after rechallenge with homologous, but not heterologous, genotypes in a chimpanzee model.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Influence of liver hepatitis C virus RNA and hepatitis C virus genotype on FAS-mediated apoptosis after liver transplantation for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Response of hepatitis C genotype-4 naïve patients to 24 weeks of Peg-interferon-alpha2b/ribavirin or induction-dose interferon-alpha2b/ribavirin/amantadine: a non-randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Insulin resistance and steatosis in hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Hepatitis C and steatosis: a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Hepatitis C virus core protein induces hepatic steatosis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Structural biology of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

Hepatitis C and liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.103

21 January 2018

Identifiers

DOI

10.2217/17460913.1.1.103

1 reference

16 August 2017

1 reference